Health Cor Management, L.P. Halozyme Therapeutics, Inc. Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $3.34 Million - $4.29 Million	-104,482 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $12.4 Million - $15.9 Million	-389,020 Reduced 78.83%	104,482 $4.2 Million
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $5.98 Million - $7.22 Million	-155,550 Reduced 23.97%	493,502 $20.1 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $3.75 Million - $4.95 Million	-96,553 Reduced 12.95%	649,052 $29.5 Million
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $29.5 Million - $38.4 Million	745,605 New	745,605 $31.1 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.54B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.